| CCT007093 |
ENSG00000100181.17 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000117242.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000117242.7 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000118412.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000124915.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000149656.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000153363.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000160336.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000163364.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000163364.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000170590.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000170846.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000175873.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000175873.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000177406.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000177822.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000179219.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000179406.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000180712.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000182109.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000182376.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000185186.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000186019.10 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000186056.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000187156.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000188424.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000189419.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000189419.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000196295.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000196295.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000196668.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000196951.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000197251.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000197308.4 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000197332.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000197332.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000197670.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000197813.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000197989.9 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000197989.9 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000203280.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000203362.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000203362.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000203499.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000203499.6 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000203588.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000203706.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000203709.5 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000204362.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000204362.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000204380.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000204623.4 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000204625.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000204837.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000204860.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000204934.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000205559.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000205662.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000205662.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000205663.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000205663.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000205913.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000205959.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000206028.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000206195.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000212552.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000212663.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000212978.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000214049.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000214293.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000214401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000214725.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000214773.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000214783.5 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000214851.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000215022.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000215023.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000215039.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000215159.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000215256.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000215304.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000215386.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000215458.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000215498.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000215692.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000219665.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000219665.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000222041.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000223374.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000223379.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000223382.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000223387.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000223393.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000223401.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000223401.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000223462.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000223473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000223477.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000223571.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000223669.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000223734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000223734.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000223764.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000223813.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000223882.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000223960.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000224020.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000224078.8 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000224079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000224157.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000224165.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000224189.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000224269.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000224281.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000224356.3 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000224429.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000224441.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000224441.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000224441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000224481.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000224490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000224509.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000224746.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000224794.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000224799.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000224805.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000224843.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000224884.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000224885.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000224930.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000224945.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000224965.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000225030.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000225037.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000225092.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000225210.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000225213.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000225216.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000225265.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000225331.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000225408.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000225489.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000225578.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000225643.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000225684.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000225721.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000225725.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000225761.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000225806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000225914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000225963.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000225969.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000225975.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000225975.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000226053.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000226125.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000226155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000226194.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000226200.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000226200.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000226266.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000226266.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000226276.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000226281.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000226291.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000226330.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000226330.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000226352.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000226416.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000226471.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000226520.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000226648.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000226649.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000226690.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000226696.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000226738.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000226752.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000226756.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000226816.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000226877.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000226877.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000226904.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000227006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000227014.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000227017.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000227017.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000227083.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000227136.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000227155.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000227155.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000227186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000227195.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000227210.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000227214.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000227218.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000227354.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000227374.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000227388.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000227398.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000227398.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000227409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000227502.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000227540.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000227598.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000227646.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000227698.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000227704.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000227719.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000227744.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000227885.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000227885.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000227888.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000227896.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000227945.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000228037.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000228043.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000228043.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000228061.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000228065.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000228106.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000228109.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000228124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000228135.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000228137.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000228141.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228176.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228201.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228223.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000228223.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000228237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000228294.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000228327.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000228327.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000228352.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000228363.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000228372.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000228386.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000228386.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228487.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000228573.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000228596.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000228643.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228649.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000228649.4 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228661.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000228679.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000228719.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000228779.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000228784.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000228794.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000228809.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000228852.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000228878.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000228889.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000228917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000228933.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228952.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000228973.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000229021.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000229043.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000229109.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000229111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000229137.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000229178.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000229190.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000229190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000229195.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000229233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000229263.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000229267.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000229291.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000229325.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000229388.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000229401.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000229487.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000229487.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000229512.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000229539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000229694.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000229719.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000229832.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000229839.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000229847.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000229989.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000229989.3 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000229990.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000229999.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000230002.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000230010.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000230021.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000230068.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000230082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000230082.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000230184.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000230212.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000230289.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000230310.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000230310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000230316.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000230368.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000230438.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000230487.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000230563.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000230724.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000230790.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000230825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000230844.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000230876.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000230925.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000230943.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000231010.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000231023.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000231024.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000231057.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000231081.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000231102.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000231105.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000231107.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000231119.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000231156.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000231185.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000231212.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000231242.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000231346.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000231363.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000231393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000231401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000231435.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000231509.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000231519.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000231528.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000231536.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000231563.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000231574.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000231607.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000231607.4 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000231607.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000231607.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000231616.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000231616.4 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000231616.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000231636.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000231663.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000231728.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000231731.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000231731.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000231734.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000231789.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000231794.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000231794.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000231856.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000231881.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000231890.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000231927.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000231948.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000231964.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000231999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000232072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000232082.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000232082.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000232093.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000232098.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000232098.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000232118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000232124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000232194.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000232224.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000232298.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000232311.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000232352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000232445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000232453.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000232455.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000232474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000232485.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000232527.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000232527.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000232527.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000232586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000232611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000232613.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000232677.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000232686.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000232712.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000232721.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000232754.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000232874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000232907.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000232931.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000232987.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000233048.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000233058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000233080.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000233080.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000233110.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000233215.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000233223.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000233296.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000233384.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000233396.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000233411.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000233411.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000233411.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000233429.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000233430.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000233452.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000233483.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000233509.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000233547.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000233554.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000233627.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000233654.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000233862.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000233895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000233901.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000233930.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000234062.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000234129.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000234141.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000234141.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000234171.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000234185.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000234193.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000234197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000234206.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000234235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000234245.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000234384.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000234396.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000234459.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000234478.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000234503.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000234506.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000234509.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000234630.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000234678.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000234684.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000234689.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000234695.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000234707.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000234753.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000234772.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000234789.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000234832.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000234869.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000234883.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000234936.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000234943.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000234997.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000235010.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000235027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000235029.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000235079.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000235100.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000235106.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000235138.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000235146.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000235159.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000235159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000235192.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000235192.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000235204.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000235214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000235262.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000235319.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000235373.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000235397.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000235423.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000235475.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000235488.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000235501.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000235522.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000235530.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000235560.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000235586.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000235706.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000235724.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000235786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000235806.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000235837.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000235843.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000235872.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000235884.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000235927.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000235954.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000235999.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000236017.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000236051.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000236065.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000236098.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000236098.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000236137.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000236212.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000236256.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000236269.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000236299.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000236333.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000236333.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000236337.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000236337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000236423.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000236423.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000236427.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000236434.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000236449.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000236471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000236472.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000236494.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000236498.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000236514.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000236519.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000236520.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000236540.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000236558.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000236717.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000236754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000236772.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000236824.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000236861.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000236861.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000236871.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000236896.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000236901.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000236914.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000236924.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000236938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000236943.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000236963.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000236983.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000237037.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000237149.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000237200.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000237200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000237298.4 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000237402.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000237407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000237410.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000237594.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000237609.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000237751.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000237772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000237805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000237862.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000237870.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000237892.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000237943.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000237943.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000237950.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000238058.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000238068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000238078.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000238123.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000238197.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000238210.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000238290.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000238358.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000239002.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000239300.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000239335.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000239377.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000239446.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000239480.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000239569.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000239653.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000239705.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000239801.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000239906.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000240015.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000240057.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000240288.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000240291.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000240453.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000240453.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000240498.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000240499.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000240549.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000240618.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000240731.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000240915.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000241469.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000241520.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000241570.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000241732.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000241732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000241818.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000241954.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000242082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000242086.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000242125.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000242190.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000242357.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000242474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000242687.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000242767.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000243008.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000243055.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000243107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000243230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000243243.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000243350.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000243415.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000243491.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000243637.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000243701.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000243701.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000243819.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000243819.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000243819.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000243849.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000243902.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000243926.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000243960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000244036.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000244124.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000244184.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000244300.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000244306.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000244327.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000244349.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000244459.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000244541.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000244926.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000244945.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000245164.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000245213.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000245248.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000245281.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000245293.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000245311.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000245322.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000245330.4 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000245573.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000245648.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000245648.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000245651.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000245685.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000245812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000246067.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000246089.3 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000246090.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000246090.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000246308.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000246582.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000246640.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000246777.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000246792.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000246982.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000247081.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000247081.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000247131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000247137.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000247151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000247151.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000247213.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000247311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000247317.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000247572.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000247595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000247624.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000247796.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000247828.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000247844.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000247844.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000247877.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000247925.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000247925.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000247950.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000248092.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000248092.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000248100.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000248112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000248175.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000248206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000248238.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000248256.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000248265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000248279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000248367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000248367.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000248489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000248576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000248576.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000248668.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000248668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000248740.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000248858.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000248925.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000249084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000249084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000249085.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000249167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000249234.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000249258.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000249348.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000249407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000249407.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000249412.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000249492.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000249532.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000249593.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000249604.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000249604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000249637.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000249650.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000249700.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000249740.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000249786.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000249791.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000249868.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000249898.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000249942.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000249996.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000250012.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000250012.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000250015.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000250027.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000250062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000250069.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000250132.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000250133.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000250133.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000250155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000250158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000250237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000250250.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000250343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000250432.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000250451.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000250490.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000250582.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000250592.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000250765.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000250786.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000250802.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000250842.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000250846.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000250900.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000250903.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000250988.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000250999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000251018.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000251072.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000251151.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000251279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000251323.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000251361.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000251361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000251442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000251497.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000251513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000251556.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000251562.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000251580.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000251602.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000251666.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000251675.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000253121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000253174.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000253190.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000253263.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000253307.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000253347.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000253358.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000253390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000253395.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000253476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000253509.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000253553.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000253636.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000253636.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000253671.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000253708.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000253712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000253716.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000253744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000253877.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000253921.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000253944.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000254027.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000254154.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000254166.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000254180.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000254231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000254275.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000254315.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000254317.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000254317.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000254353.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000254369.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000254409.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000254419.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000254427.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000254432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000254461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000254468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000254473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000254473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000254480.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000254486.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000254556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000254604.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000254631.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000254718.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000254731.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000254791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000254812.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000254833.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000254860.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000254869.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000254900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000254907.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000254966.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000254973.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000254987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000254990.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000254991.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000255052.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000255153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000255153.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000255160.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000255308.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000255348.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000255375.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000255409.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000255409.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000255410.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000255449.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000255449.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000255474.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000255503.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000255507.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000255669.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000255847.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000255959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000255989.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000256092.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000256101.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000256116.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000256196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000256226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000256226.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000256248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000256278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000256314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000256360.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000256433.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000256448.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000256448.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000256458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000256481.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000256481.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000256546.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000256588.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000256603.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000256670.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000256739.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000256739.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000256746.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000256894.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000256897.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000257002.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000257137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000257222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000257279.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000257285.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000257381.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000257381.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000257497.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000257515.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000257526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000257527.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000257527.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000257534.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000257557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000257596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000257681.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000257696.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000257698.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000257702.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000257740.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000257769.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000258001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000258035.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000258044.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000258082.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000258086.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000258096.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000258096.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000258101.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000258102.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000258122.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000258136.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000258137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000258168.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000258188.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000258260.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000258260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000258301.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000258302.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000258378.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000258378.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000258443.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000258454.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000258558.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000258593.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000258609.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000258658.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000258673.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000258701.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000258702.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000258777.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000258809.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000258809.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000258813.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000258821.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000258825.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000258825.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000258922.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000258938.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000258938.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000258940.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000258982.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000259039.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000259163.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000259198.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000259206.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000259250.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000259250.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000259274.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000259310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000259322.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000259343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000259345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000259364.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000259364.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000259380.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000259396.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000259407.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000259407.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000259416.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000259424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000259442.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000259442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000259444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000259462.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000259474.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000259475.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000259475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000259523.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000259540.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000259542.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000259561.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000259577.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000259583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000259595.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000259628.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000259628.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000259644.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000259673.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000259673.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000259673.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000259687.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000259694.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000259715.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000259727.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000259744.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000259744.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000259762.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000259762.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000259768.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000259783.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000259783.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000259798.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000259806.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000259818.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000259869.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000259871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000259876.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000259877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000259886.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000259894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000259894.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000259915.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260022.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260038.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260046.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000260059.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260060.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000260084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000260091.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000260156.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000260176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000260190.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000260190.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000260206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000260231.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000260248.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000260248.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000260257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260260.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260285.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000260296.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000260310.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260331.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000260351.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000260360.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000260367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260369.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000260381.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000260411.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000260411.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000260417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000260417.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260430.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000260439.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000260439.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000260448.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000260464.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000260475.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000260475.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000260493.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000260534.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000260552.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000260572.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000260589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260601.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260612.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260618.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000260625.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260641.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260646.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000260647.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000260648.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260657.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000260698.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000260711.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260773.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260778.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260796.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000260816.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260837.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000260855.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000260874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260874.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000260896.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000260911.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000260912.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000260938.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000260941.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000260949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000260954.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000260986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000260988.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000261002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000261040.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000261043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261043.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000261043.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000261064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000261069.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000261087.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000261094.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261168.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000261172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000261173.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261175.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000261189.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000261211.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000261220.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000261220.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000261241.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000261248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000261252.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261280.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000261288.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000261291.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000261302.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000261337.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000261353.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000261357.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000261374.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000261428.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000261430.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000261455.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000261481.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000261485.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000261550.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000261560.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261584.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000261600.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000261610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261613.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000261654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000261663.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000261664.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000261673.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000261690.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000261692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261737.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000261760.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000261775.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000261777.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000261801.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000261823.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000261824.2 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000261837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000261838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000261864.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000261889.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000261925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000261971.2 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000262074.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000262094.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000262094.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000262155.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000262172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000262185.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000262202.3 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000262213.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000262319.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000262319.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000262319.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000262482.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000262652.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000262662.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000262768.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000262777.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000262786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000262810.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000262873.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000262952.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000262952.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000262979.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000263013.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000263050.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000263063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000263069.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000263069.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000263069.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000263300.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000263307.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000263316.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000263327.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000263388.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000263499.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000263603.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000263683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000263727.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000263731.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000263786.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000263859.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000263874.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000263884.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000263923.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000264078.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000264235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000264304.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000264451.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000264513.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000264513.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000264520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000264520.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000264575.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000264647.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000264672.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000264745.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000264769.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000264808.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000264812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000264914.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000264932.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000264937.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000265008.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000265055.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000265142.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000265204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000265205.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000265342.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000265394.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000265399.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000265443.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000265479.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000265496.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000265496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000265688.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000265778.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000265800.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000266111.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000266236.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000266256.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000266313.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000266371.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000266601.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000266644.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000266696.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000266783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000266805.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000266850.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000266900.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000266900.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000266922.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000266933.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000266942.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000266993.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000267006.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000267009.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267015.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000267016.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000267052.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000267058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000267064.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267067.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000267073.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267096.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000267104.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000267143.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267143.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000267147.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000267167.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000267169.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000267191.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000267191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000267199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267212.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000267248.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000267277.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000267296.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000267308.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267321.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000267342.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000267344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000267394.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267394.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000267395.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000267416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000267421.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000267437.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000267475.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000267504.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000267505.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267505.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000267510.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000267522.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267547.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267582.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267586.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000267655.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000267658.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000267658.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000267662.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000267667.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267682.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000267696.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000267715.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267731.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000267745.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267747.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000267750.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000267778.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000267785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000267787.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000267798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267898.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000267939.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000267940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000267940.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000268001.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000268066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000268066.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000268095.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000268189.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000268199.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000268230.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000268289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000268366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000268375.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000268520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000268530.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000268549.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000268564.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000268568.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000268621.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000268650.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000268670.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000268707.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000268764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000268836.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000268889.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000268970.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000268970.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000268987.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000269019.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000269082.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000269082.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000269102.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000269148.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000269161.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000269161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000269161.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000269246.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000269290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000269386.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000269416.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000269423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000269463.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000269473.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000269480.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000269480.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000269483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000269487.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000269609.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000269646.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000269652.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000269696.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000269720.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000269720.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000269910.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000269923.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000269924.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000269925.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000269940.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000269949.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000269958.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000269959.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000269961.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000269979.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000270015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000270015.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000270020.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000270036.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000270039.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000270049.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000270055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000270062.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000270068.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000270072.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000270091.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000270097.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000270105.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000270124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000270133.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000270133.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000270145.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000270159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000270178.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000270190.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000270195.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000270265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000270361.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000270361.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000270482.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000270607.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000270641.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000270760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000270828.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000270876.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000270951.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000271127.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000271133.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000271151.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000271200.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000271265.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000271265.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000271308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000271427.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000271553.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000271555.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000271593.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000271709.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000271738.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000271751.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000271752.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000271781.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000271782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000271788.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000271788.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000271835.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000271862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000271862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000271869.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000271912.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000271921.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000271926.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000271930.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000271967.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000271981.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000271983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000271983.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000271992.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000271992.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000272004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272010.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272023.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272023.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000272024.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000272029.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272033.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000272040.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272057.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272072.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000272093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272097.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272097.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272097.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000272112.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272121.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000272123.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000272128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000272128.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272129.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272158.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272180.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000272180.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272264.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272288.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000272320.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272338.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272369.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000272377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000272386.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272402.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272406.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000272417.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272426.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000272431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000272440.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272440.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000272452.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000272465.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272489.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272506.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000272508.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272512.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272516.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272523.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000272544.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272551.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000272556.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272556.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272556.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272562.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000272567.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000272576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272588.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272588.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000272604.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000272620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000272627.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000272627.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272650.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272657.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272662.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000272663.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000272666.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272668.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000272677.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000272688.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000272689.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000272692.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000272696.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272717.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000272717.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272720.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272724.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000272744.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000272760.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272763.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000272777.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272798.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000272829.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000272836.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000272849.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000272894.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000272902.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272902.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000272917.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000272933.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272942.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000272945.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000272949.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000272950.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000272995.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000273009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000273011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000273027.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000273033.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000273038.1 |
Predicted lncRNA |
Esophageal cancer |
|
| CCT007093 |
ENSG00000273069.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000273073.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| CCT007093 |
ENSG00000273142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000273145.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| CCT007093 |
ENSG00000273153.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000273175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000273183.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000273186.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000273190.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| CCT007093 |
ENSG00000273218.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| CCT007093 |
ENSG00000273230.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000273237.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000273248.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000273270.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000273272.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000273308.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| CCT007093 |
ENSG00000273311.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000273338.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000273343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000273355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| CCT007093 |
ENSG00000273355.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000273381.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| CCT007093 |
ENSG00000273384.1 |
Predicted lncRNA |
Sarcoma |
|
| CCT007093 |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| CCT007093 |
ENSG00000273443.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000273447.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000273448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| CCT007093 |
ENSG00000273449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000273456.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000273464.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| CCT007093 |
ENSG00000273481.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| CCT007093 |
ENSG00000273486.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| CCT007093 |
ENSG00000273488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
